Published in J Immunol Methods on November 28, 1985
Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q. J Clin Invest (1988) 1.07
T cells and in situ cryoglobulin deposition in the pathogenesis of lupus nephritis. Clin Immunol (2008) 1.04
C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus. Clin Exp Immunol (1987) 0.91
Elevated C-reactive protein levels in overweight and obese adults. JAMA (1999) 9.94
Individual Antigenic Specificity of Isolated Antibodies. Science (1963) 7.27
A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet (2001) 4.17
A 17-kD centromere protein (CENP-A) copurifies with nucleosome core particles and with histones. J Cell Biol (1987) 3.92
Saturation of the reticuloendothelial system with soluble immune complexes. J Immunol (1974) 3.65
Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med (1993) 3.51
Studies on antigen-antibody complexes. I. Elimination of soluble complexes from rabbit circulation. J Exp Med (1971) 3.51
The macrophage receptor for IgG: number and affinity of binding sites. J Immunol (1973) 2.91
Telophase disc: a new mammalian mitotic organelle that bisects telophase cells with a possible function in cytokinesis. J Cell Sci (1991) 2.32
Role of marrow-derived monocytes and mesangial cells in removal of immune complexes from renal glomeruli. J Exp Med (1979) 2.27
In vitro adherence of soluble immune complexes to macrophages. J Exp Med (1972) 2.26
Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels. J Intern Med (2013) 2.22
Immunoglobulins in temporal arteries. An immunofluorescent study. Ann Intern Med (1974) 2.02
The glomerular deposition of soluble immune complexes prepared with reduced and alkylated antibodies and with intact antibodies in mice. Lab Invest (1976) 2.01
Low-grade systemic inflammation in overweight children. Pediatrics (2001) 1.99
The disappearance kinetics of soluble immune complexes prepared with reduced and alkylated antibodies and with intact antibodies in mice. Lab Invest (1976) 1.84
Studies on antigen-antibody complexes. II. Quantification of tissue uptake of soluble complexes in normal and complement-depleted rabbits. J Immunol (1971) 1.77
The molecular basis of self-association of antibodies to IgG (rheumatoid factors) in rheumatoid arthritis. Proc Natl Acad Sci U S A (1974) 1.76
Specificity of recombination of H and L chains from human gamma-G-myeloma proteins. J Exp Med (1965) 1.69
Molecular composition and sedimentation characteristics of soluble antigen-antibody complexes. Biochemistry (1972) 1.64
Effect of cortisone on the disappearance kinetics and tissue localization of soluble immune complexes. J Immunol (1975) 1.62
Antigen retention in joint tissues in antigen-induced synovitis. Clin Exp Immunol (1974) 1.61
Human IgM molecules that bind staphylococcal protein A contain VHIII H chains. J Immunol (1989) 1.59
Effect of cationized antibodies in performed immune complexes on deposition and persistence in renal glomeruli. J Exp Med (1982) 1.54
Antibody-agarose immunoadsorbents: complete removal of classes of immunoglobulins from serum. J Immunol (1971) 1.54
The hyperviscosity syndrome in rheumatoid arthritis due to intermediate complexes formed by self-association of IgG-rheumatoid factors. Arthritis Rheum (1975) 1.54
The disappearance kinetics and glomerular deposition of small-latticed soluble immune complexes. Immunology (1982) 1.54
Human IgA and IgG F(ab')2 that bind to staphylococcal protein A belong to the VHIII subgroup. J Immunol (1991) 1.49
Rheumatoid factor, HLA-DR4, and allelic variants of DRB1 in women with recent-onset rheumatoid arthritis. Arthritis Rheum (1994) 1.49
Kinetics and mechanisms for removal of circulating single-stranded DNA in mice. J Exp Med (1978) 1.46
Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice. Am J Pathol (2001) 1.45
Renal manifestations of hepatitis C virus infection. Kidney Int (1994) 1.43
Removal of glomerular deposits of immune complexes in mice by administration of excess antigen. Lab Invest (1980) 1.42
Drug induced systemic lupus erythematosus due to ophthalmic timolol. J Rheumatol (1992) 1.41
Amniotic fluid alpha-fetoprotein determination at the time of genetic amniocentesis: has it outlived its usefulness? J Ultrasound Med (1996) 1.39
Neural networks as expert systems in rheumatic disease diagnosis: artificial intelligence or intelligent artifice? J Rheumatol (1993) 1.39
The distribution of antigenic determinants in rat skin collagen. J Exp Med (1971) 1.35
Clearance kinetics and fate of mouse IgA immune complexes prepared with monomeric or dimeric IgA. J Immunol (1983) 1.34
Diagnostic value of antibodies to filaggrin in rheumatoid arthritis. J Rheumatol (1998) 1.32
Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. Am J Med (1995) 1.31
Clearance of circulating IgA immune complexes is mediated by a specific receptor on Kupffer cells in mice. J Exp Med (1984) 1.31
Pathophysiology of circulating immune complexes. Arthritis Rheum (1982) 1.28
Binding of albumin to gamma-A-myeloma proteins and Waldenström macroglobulins by disulfide bonds. J Immunol (1967) 1.28
The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A. J Exp Med (1993) 1.26
Clearance of circulating DNA-anti-DNA immune complexes in mice. J Exp Med (1982) 1.23
Risk factors for repeatedly reactive HIV-1 EIA and indeterminate western blots. A population-based case-control study. Arch Intern Med (1994) 1.22
Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection. Ann Rheum Dis (2003) 1.20
Clearance and tissue uptake of immune complexes in complement-depleted and control mice. Immunology (1981) 1.20
The molecular basis of self-association of IgG-Rheumatoid factors. J Immunol (1975) 1.19
IgG rheumatoid factors and staphylococcal protein A bind to a common molecular site on IgG. J Exp Med (1985) 1.18
Utility of laboratory testing in autoimmune inner ear disease. Laryngoscope (1999) 1.17
Biological variation of prostate specific antigen levels in serum: an evaluation of day-to-day physiological fluctuations in a well-defined cohort of 24 patients. J Urol (1997) 1.17
Effect of DNA size and strandedness on the in vivo clearance and organ localization of DNA. Clin Exp Immunol (1984) 1.15
Blood clearance kinetics and liver uptake of mononucleosomes in mice. J Immunol (1996) 1.15
Fate of preformed immune complexes in rabbits and rhesus monkeys. J Exp Med (1971) 1.14
C-reactive protein in normal pregnancy. Obstet Gynecol (1991) 1.14
Determination of soluble immune complex molar composition and antibody association constants by ammonium sulfate precipitation. J Immunol (1974) 1.14
7S M-globulin in rheumatoid arthritis. Evaluation of its clinical significance. Arthritis Rheum (1971) 1.13
Studies on the antigenic determinants in the self-association of IgG rheumatoid factor. J Exp Med (1981) 1.12
Precipitating antigen-antibody systems are required for the formation of subepithelial electron-dense immune deposits in rat glomeruli. J Exp Med (1983) 1.11
Rearrangement of immune complexes in glomeruli leads to persistence and development of electron-dense deposits. J Exp Med (1983) 1.09
Glomerulonephritis with anti-glomerular basement membrane antibody during pregnancy: potential role of the placenta in amelioration of disease. Am J Kidney Dis (1995) 1.09
Nonimmunospecific protein-protein interactions of IgG: studies of the binding of IgG to IgG immunoadsorbents. J Immunol (1978) 1.08
Physicochemical and functional relationships of immune complexes. J Invest Dermatol (1980) 1.07
Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q. J Clin Invest (1988) 1.07
Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases. Arthritis Rheum (1989) 1.05
SR proteins are autoantigens in patients with systemic lupus erythematosus. Importance of phosphoepitopes. Arthritis Rheum (2000) 1.05
Intermediate complexes formed by self-association of IgG-rheumatoid factors. Ann N Y Acad Sci (1975) 1.05
Self-associating IgG rheumatoid factors in MRL/l autoimmune mice. Arthritis Rheum (1984) 1.04
Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum (1997) 1.04
Glomerular localization of preformed immune complexes prepared with anionic antibodies or with cationic antigens. Lab Invest (1984) 1.03
Screening for prostatic carcinoma with prostate specific antigen: results of the second year. J Urol (1993) 1.02
IgG rheumatoid factors and self-association of these antibodies. Clin Rheum Dis (1985) 1.01
Emerging human B cell repertoire. Influence of developmental stage and interindividual variation. J Immunol (1992) 1.01
Serum sickness secondary to treatment with the murine-human chimeric antibody IDEC-C2B8 (rituximab). Arthritis Rheum (2001) 1.00
Interaction between herpes simplex type 1-induced Fc receptor and human and rabbit immunoglobulin G (IgG) domains. Immunology (1986) 1.00
Rheumatoid factors from patients with rheumatoid arthritis possess private repertoires of idiotypes. J Immunol (1987) 1.00
Evaluation of immunological specificity of flurescein-conjugated antisera with agarose-antigen sections. Infect Immun (1975) 1.00
Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. J Rheumatol (1997) 1.00
Covalent binding of molecules to CNBr-activated agarose: parameters relevant to the activation and coupling reactions. Biochim Biophys Acta (1974) 1.00
Rheumatoid factors in rheumatoid arthritis. Bull Rheum Dis (1973) 0.98
Evaluation of aggregated IgG in mice as an Fc receptor specific probe of the hepatic mononuclear phagocyte system. Clin Exp Immunol (1982) 0.98
Effect of preformed immune complexes on the clearance and tissue localization of single-stranded DNA in mice. Clin Exp Immunol (1980) 0.98
Self-associating IgG rheumatoid factors stimulate monocytes to release prostaglandins and mononuclear cell factor that stimulates collagenase and prostaglandin production by synovial cells. Rheumatol Int (1983) 0.97
Mechanisms of tissue deposition of immune complexes. J Rheumatol Suppl (1987) 0.96
Autoantibodies to the collagen-like region of C1Q deposit in glomeruli via C1Q in immune deposits. Clin Immunol Immunopathol (1991) 0.96
Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus. Medicine (Baltimore) (1987) 0.96
Iatrogenic immunization with bovine thrombin: a mechanism for prolonged thrombin times after surgery. Ann Intern Med (1989) 0.96
Antigenic specificities of human monoclonal and polyclonal IgM rheumatoid factors. The C gamma 2-C gamma 3 interface region contains the major determinants. J Immunol (1988) 0.94
A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children. Arthritis Rheum (1994) 0.94
Hepatitis C virus and rheumatic disease. J Rheumatol (1996) 0.94
Covalently cross-linked immune complexes prepared with multivalent cross-linking antigens. J Immunol (1981) 0.93
Removal of glomerular immune complex deposits by excess antigen in chronic mouse model of immune complex disease. Lab Invest (1983) 0.93
Immunologically induced acute synovitis in rabbits. Studies of immune complexes in synovial fluid. Arthritis Rheum (1973) 0.92
Hepatic uptake of small-latticed immune complexes does not alter mononuclear phagocyte system function. Immunology (1983) 0.90
Blood viscosity in Waldenström's macroglobulinemia. Blood (1974) 0.90
Cranial settling in rheumatoid arthritis. Radiology (1980) 0.89
Mechanisms of immune deposit formation in renal glomeruli. Springer Semin Immunopathol (1986) 0.89